Clover Health Investments Corp. Cl A (CLOV): Price and Financial Metrics


Clover Health Investments Corp. Cl A (CLOV): $1.36

0.03 (+2.26%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CLOV POWR Grades

  • CLOV scores best on the Quality dimension, with a Quality rank ahead of 54.77% of US stocks.
  • The strongest trend for CLOV is in Growth, which has been heading down over the past 179 days.
  • CLOV ranks lowest in Stability; there it ranks in the 2nd percentile.

CLOV Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for CLOV is 7.68 -- better than 95.17% of US stocks.
  • CLOV's price/sales ratio is 0.19; that's higher than the P/S ratio of merely 5.18% of US stocks.
  • As for revenue growth, note that CLOV's revenue has grown 149.54% over the past 12 months; that beats the revenue growth of 94.44% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CLOVER HEALTH INVESTMENTS CORP are JUPW, TIRX, EEIQ, TRC, and SGLY.
  • CLOV's SEC filings can be seen here. And to visit CLOVER HEALTH INVESTMENTS CORP's official web site, go to www.cloverhealth.com.

CLOV Valuation Summary

  • CLOV's price/earnings ratio is -1.4; this is 106.03% lower than that of the median Healthcare stock.
  • CLOV's price/sales ratio has moved down 1.3 over the prior 32 months.

Below are key valuation metrics over time for CLOV.

Stock Date P/S P/B P/E EV/EBIT
CLOV 2022-11-25 0.2 1.6 -1.4 -0.6
CLOV 2022-11-23 0.2 1.5 -1.3 -0.5
CLOV 2022-11-22 0.2 1.5 -1.4 -0.5
CLOV 2022-11-21 0.2 1.5 -1.3 -0.5
CLOV 2022-11-18 0.2 1.6 -1.4 -0.6
CLOV 2022-11-17 0.2 1.6 -1.4 -0.6

CLOV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CLOV has a Quality Grade of C, ranking ahead of 33.49% of graded US stocks.
  • CLOV's asset turnover comes in at 1.618 -- ranking 5th of 133 Insurance stocks.
  • 500 - Internal server error

The table below shows CLOV's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.618 0.009 -0.991
2021-03-31 1.251 0.098 -0.276
2020-12-31 1.398 0.148 -0.223
2020-09-30 1.222 0.222 0.038
2020-09-30 0.000 NA -0.006

CLOV Price Target

For more insight on analysts targets of CLOV, see our CLOV price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.00 Average Broker Recommendation 2.3 (Moderate Sell)

CLOV Stock Price Chart Interactive Chart >

Price chart for CLOV

CLOV Price/Volume Stats

Current price $1.36 52-week high $4.80
Prev. close $1.33 52-week low $1.21
Day low $1.27 Volume 5,185,200
Day high $1.37 Avg. volume 10,000,055
50-day MA $1.52 Dividend yield N/A
200-day MA $2.43 Market Cap 650.00M

Clover Health Investments Corp. Cl A (CLOV) Company Bio


Clover Health Investments, Corp. provides health insurance services. The company was founded in 2012 and is based in Franklin, Tennessee.


CLOV Latest News Stream


Event/Time News Detail
Loading, please wait...

CLOV Latest Social Stream


Loading social stream, please wait...

View Full CLOV Social Stream

Latest CLOV News From Around the Web

Below are the latest news stories about CLOVER HEALTH INVESTMENTS CORP that investors may wish to consider to help them evaluate CLOV as an investment opportunity.

6 Penny Stocks to Sell Right Now … And 1 to Buy

Don't be tempted by the ultra-low price of these penny stocks.

Ian Bezek on InvestorPlace | November 18, 2022

Clovis Oncology (CLVS) Stock Pops After Bankruptcy Warning

Today, speculators are bidding up shares of Clovis Oncology and CLVS stock, after the company announced bankruptcy concerns.

Chris MacDonald on InvestorPlace | November 14, 2022

7 Penny Stocks Smart Investors Shouldn’t Touch With a 10-Foot Pole

Don't let the recent bull market rally fool you into thinking these seven penny stocks to avoid are worthwhile moonshots.

Thomas Niel on InvestorPlace | November 13, 2022

Clover Health Reports Third Quarter 2022 Financial Results

Third quarter Insurance MCR of 86.3% and year-to-date Insurance MCR of 91.7% demonstrate positive momentum The Company updates 2022 full year guidance to include improved 2022 Insurance MCR range of 93% to 94% Clover intends to continue to grow Insurance business at above-market rates in 2023 but will moderate growth to prioritize profitability Company outlines strategic reduction in number of ACO REACH participating physicians in 2023; targeting Non-Insurance MCR below 100% The Company reports

Yahoo | November 7, 2022

Clover Health to Present at Credit Suisse 31st Annual Healthcare Conference on November 10, 2022

FRANKLIN, Tenn., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the Credit Suisse 31st Annual Healthcare Conference on Thursday, November 10, 2022, at 12:10 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations websi

Yahoo | November 3, 2022

Read More 'CLOV' Stories Here

CLOV Price Returns

1-mo -4.23%
3-mo -43.57%
6-mo -46.03%
1-year -68.37%
3-year N/A
5-year N/A
YTD -63.44%
2021 -77.82%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6343 seconds.